Weatherden is a leading early clinical development company with a unique model providing partners with rapid, expert, high-quality drug development solutions. Facilitated by global relationships with external experts in all therapeutic areas, Weatherden’s experience extends to all aspects of translational drug discovery and development.
Emerging Biotech and small-to-medium Biopharma companies
Programmes targeting diseases resulting in major morbidity and mortality with significant unmet need
Novel platforms and technologies
Build companies around novel scientific ideas
Blending more than 150 years’ experience across the R&D chain, Weatherden is clinician-led and specialises in de-risking drug discovery and drug development across all therapeutic areas. Our teams execute target discovery and target re/validation programs in commercial and academic settings across North America and Europe, bringing new drugs to market, retargeting existing products, and realising the potential of unexplored ideas.
Right decision & execution